EAM
AGTC

Empery Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Empery Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100,000
Closed -$107K – 85
2022
Q1 		$107K Buy
+100,000
New +$182K 0.5% 29

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Empery Asset Management's AGTC Position: Q2 2022 in Review

Empery Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2022, closing a stake of 100,000 shares — an estimated $107K sold.

Empery Asset Management first reported a position in AGTC in Q1 2022 and held it in 1 quarter. The position peaked at $107K in Q1 2022. 47 funds tracked by Wall St. Rank hold AGTC as of Q2 2022.

  • Empery Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2022 after selling out during the quarter.
  • Empery Asset Management sold 100,000 Applied Genetic Technologies Corporation shares in Q2 2022, an estimated $107K.
  • Empery Asset Management first reported a position in Applied Genetic Technologies Corporation in Q1 2022 and held it in 1 quarter.
  • Empery Asset Management's Applied Genetic Technologies Corporation position peaked at $107K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2022.

Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.